Dermatomyositis Recruiting Phase 3 Trials for Abatacept (DB01281)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs